anticip zoeti wide econom moat grow stronger
long term
updat forecast estim apr
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim apr
price data apr
rate updat apr
currenc amount express
valuat growth profit
methodolog valu compani
zoeti clear leader global anim health industri
believ possess widest moat player
industri whole possess mani characterist
conduc moat zoeti global infrastructur give cost
advantag peer firm also fend competit
impress breadth product portfolio
includ number drug specif canin felin ailment
anim health industri larg ignor
busi often buri within larger human health compani
mani attract characterist includ cash-pay
buyer fragment custom base minim gener
competit due fragment cash-pay custom base
anim drugmak hold signific price power human
health side firm tradit merci payer
govern payer larg managed-car organ
power forc gener util squash price increas even
extrem case forc price cut onto drug manufactur
howev anim health product purchas fragment
group protein produc veterinarian pet owner allow
littl bargain power highli concentr anim
industri also benefit favor growth tailwind
allow zoeti increas revenu mid-single-digit
long-term growth rate product anim side rise
standard live emerg market lead wider
adopt meat-heavi diet drive greater demand livestock
product companion side zoeti benefit pet owner
increasingli strong relationship pet member
famili drastic increas willing pay
expens treatment zoeti like grow rate rel
close industri abl maintain
above-averag margin due scale especi emerg
market zoeti scale allow use salesforc
smaller competitor often forc reli expens
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
zoeti sell anti-infect vaccin parasiticid diagnost
health product anim firm earn total revenu
product anim cattl pig poultri companion
anim dog hors cat product make remaind firm
largest market share industri previous anim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
valuat growth profit apr
boost fair valu estim per
share primarili reflect zoeti new tax rate
roughli basi point lower origin
anticip also includ slightli optimist
project improv profit longer term
continu estim low-double-digit annual growth
companion anim segment
project growth earn interest
long term
ration
remain favor profit gain follow
product portfolio
invest brand companion anim drug busi
project adjust oper margin reach
basi point next five year
expect improv split nearli evenli
gain gross margin thank slim
product portfolio product anim consolid
manufactur site half driven
effici deploy sale field support howev
benefit firm effici program
slightli off-set lower-margin emerg market make
grow portion zoeti sale well greater
 invest maintain brand drug innov
whole project factor translat
adjust averag annual earn growth
base averag volatil cash flow divers
product portfolio anim health market rate
zoeti uncertainti medium
base case forecast long-term tax rate
long-term oper margin firm
abl boost sale product anim product
leverag greater price power companion anim
portfolio project adjust oper margin
fair valu estim would per share firm
lose revenu due greater restrict
antibiot use anim face flat oper margin
penetr emerg market pressur profit
fair valu would fall per share
zoeti enjoy wide econom moat thank intang
asset scale although patent essenti
maintain product anim health industri least
firm revenu come product protect
patent allow zoeti charg premium price
insul competit firm strong brand name
anoth advantag competitor custom
use drug potenti million dollar worth
livestock pet love like famili member
will pay premium buy firm trust
zoeti also enjoy anoth intang asset comparison
competitor embed larger human
pharmaceut firm zoeti free develop therapeut
base unmet anim need competitor applic
therapeut origin design human anim
market also mean firm unlik invest
animal-specif therapi sizabl opportun
relat unmet anim need zoeti pioneer
includ cytopoint canin allergi
scale also provid zoeti key advantag
highli fragment custom base salesforc
distribut relationship extrem import
launch new product simpl get one
larg payer managed-car organ medicar
govern board compani need individu
deal veterinarian meat produc zoeti broad
portfolio support salesforc allow firm
bypass distributor
barrier entri signific capit time
although nearli expens time-consum
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
human health still challeng bring new
anim health product market given small market
size rel modest sale potenti product
reward often justifi new competitor pursu
clinic trial bring product market
one best exampl strength zoeti moat
pain medic dog rimadyl product lost
patent exclus sale current
higher vet relationship trust
zoeti allow rimadyl maintain increas
believ zoeti stabl moat trend compani
compet matur industri experienc
signific chang heavi concentr among
top firm revolutionari product develop
expect industri face materi chang
competit landscap
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oimprov standard live emerg market
drive greater adopt meat-heavi diet
longer term
ostrict regul restrict antibiot use
ocompanion anim increasingli view famili
spend pet healthcar
olower-margin emerging-market sale make
increas portion compani sale creat
headwind zoeti margin
osinc anim health industri lack larg payer
like medicar single-pay govern larg
oemerging-market custom may price-
sensit open use gener product
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
zoeti enjoy solid financi flexibl even leverag
tick financ purchas pharmaq
abbott anim health busi long-term debt
billion end zoeti alreadi brought
debt/ebitda time time two
year leverag low end target rang
time manag aim remain
comfort interest coverag around time
base averag volatil cash flow divers
product portfolio anim health market rate
zoeti uncertainti medium thank grow consum
concern use antibiot food suppli
meat product industri final begun react
industri alreadi roll new standard call
voluntari monitor use anim howev
grassroot pressur continu build risk
fda could eventu issu restrict guidelin
product anim segment offer rel
steadi growth remain expos macroeconom trend
emerg market adopt higher-protein diet
like fuel underli demand zoeti product
slower growth china brazil rippl effect could
reach zoeti companion anim market price
elast pet health care clear pet owner continu
spend pet point rise price
may owner will bear
segment market vulner macroeconom
downturn caus consum pull back spend
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
base nearli three year sinc zoeti spun
give firm standard stewardship rate
ceo juan ramon alaix previous ran busi
presid anim health busi firm
separ leadership anim health unit
success integr fort dodg anim health
alpharma acquisit region
presid central/southern europ
pharmaceut divis believ seven year run
compani give signific oper experi
thu far alaix focus increas zoeti scale
breadth seri acquisit allow
firm enter adjac market includ aquacultur
monoclon antibodi pet
abrupt departur former cfo paul herendeen
valeant last spring glenn david step role
david longtim veteran deep experi
healthcar well acquisit integr
new busi expect see dramat
departur firm current strategi serial
acquisit though leverag may settl lower
expect herendeen aggress stanc
repres date owner name posit common share held report holder issuer
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
zoeti wrap impress fourth-quart
result slightli exceed expect top
line met bottom line slight adjust
model materi shift valuat
leav fair valu unchang total quarterli
oper revenu growth clock zoeti
enjoy double-digit growth across livestock
companion anim segment well
cost advantag abil focu research
develop sole unmet anim need remain
confid firm wide econom moat good
companion anim segment consist
offer robust growth thank new product secular
trend pet ownership livestock busi
vulner extern factor diseas
outbreak herd time send livestock
feedlot fourth quarter weather condit
increas diseas risk cattl place feedlot
provid set promot adopt zoeti
macroeconom condit set scene continu
strength segment
although manag tend keep wrap
competit reason intrigu pipelin
possibl manag indic companion
anim pain area interest zoeti benefit
leadership categori rimadyl gener
encroach addit aratana therapeut
launch new nonsteroid anti-inflammatori dog
pressur gener new brand
competit zoeti could stand benefit new option
therapeut area shore leadership
also keep eye zoeti entranc
diagnost market high-volum carysta analyz
would put zoeti direct competit
lab establish domin leader
bench-top analyz vet though mani smaller
competitor much lower-pr test panel long
attempt loosen idexx hold market none
success none previou
competitor breadth portfolio depth
resourc zoeti bring tabl preliminari
stage still think enjoy advantag
extens instal base abil consist offer
innov test particularli close relationship
veterinarian addit zoeti analyz
appropri high-volum practic refer lab
could keep make notabl inroad idexx
zoeti report strong third-quart perform
weve substanti boost fair valu estim
per share reflect more-optimist project
companion anim segment midterm
well higher expect compani growth
longer term think firm success string new
companion anim product underscor strength
zoeti wide econom moat unlik competitor
zoeti liber develop therapi specif
address unmet need pet contrast anim health
divis within larg pharmaceut compani
typic bound whatev therapi origin
develop human health need find anoth
applic anim market flexibl allow
zoeti penetr domin area anim health
competitor unlik enter
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
domest livestock segment remain soft thank
lower rate diseas veterinari feed direct
seek elimin antibiot product
purpos limit usag therapeut situat
companion anim busi compens
oper growth year year zoeti
assembl formid set dermatolog product
launch apoquel cytopoint consid
product earli life cycl along parasiticid
simparica expect sustain robust growth
midterm adopt continu product
launch foreign market zoeti continu
make steadi progress rais profit
adjust oper margin hit third quarter
expect ration stock-keep unit
addit new manufactur facil china
help bolster oper margin
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
